{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:44:21Z","timestamp":1770284661506,"version":"3.49.0"},"reference-count":83,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>To date, billions of vaccine doses have been administered to restrain the current COVID-19 pandemic worldwide. Rare side effects, including intravascular blood clots, were reported in the general population after vaccination. Among these, cerebral venous sinus thrombosis (CVST) has been considered the most serious one. To shed further light on such an event, we conducted a literature search for case descriptions of CVST in vaccinated people. Findings were analyzed with emphasis on demographic characteristics, type of vaccine, site of thrombosis, clinical and histopathological findings. From 258 potential articles published till September 2021, 41 studies were retrieved for a total of 552 patients. Of these, 492 patients (89.1%) had received AZD1222\/Vaxzevria, 45 (8.2%) BNT162b2\/CX-024414 Spikevax, 15 (2.7%) JNJ-78436735, and 2 (0.3%) Covishield vaccine. CVST occurred in 382 women and 170 men (mean aged 44 years), and the median timing from the shot was 9 days (range 2\u201345). Thrombi were predominantly seen in transverse (84%), sigmoid (66%), and\/or superior sagittal (56%) sinuses. Brain injury (chiefly intracranial bleeding) occurred in 32% of cases. Of 426 patients with detailed clinical course, 63% were discharged in good clinical conditions, at times with variable neurological sequelae, whereas 37% deceased, largely due to brain injury. This narrative review confirmed CVST as a rare event after (adenoviral vector) COVID-19 vaccination, with a women\/men rate ratio of 2.25. Though the pathogenesis of thrombosis is still under discussion, currently available histopathological findings likely indicate an underlying immune vasculitis.<\/jats:p>","DOI":"10.3390\/vaccines10020232","type":"journal-article","created":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T20:40:18Z","timestamp":1644180018000},"page":"232","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cerebral Venous Sinus Thrombosis following COVID-19 Vaccination: Analysis of 552 Worldwide Cases"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3022-266X","authenticated-orcid":false,"given":"Cesare","family":"de Gregorio","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Division of Cardiology, G. Martino University Hospital Medical School of Messina, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2946-0724","authenticated-orcid":false,"given":"Luigi","family":"Colarusso","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Division of Cardiology, G. Martino University Hospital Medical School of Messina, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Calcaterra","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Postgraduate Medical School of Cardiology, University of Palermo, 90127 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8374-0260","authenticated-orcid":false,"given":"Pier Paolo","family":"Bassareo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mater Misericordiae University Hospital Crumlin, University College of Dublin, D07R2WY Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ieni","sequence":"additional","affiliation":[{"name":"Pathology Unit, Department of Human Pathology G. Barresi, G. Martino University Hospital Medical School of Messina, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Teresa","family":"Mazzeo","sequence":"additional","affiliation":[{"name":"Department of Human Pathology G. Barresi, Division of Anesthesia and Critical Care, G. Martino University Hospital Medical School of Messina, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Ferrazzo","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Division of Cardiology, G. Martino University Hospital Medical School of Messina, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Noto","sequence":"additional","affiliation":[{"name":"Department of Human Pathology G. Barresi, Division of Anesthesia and Critical Care, G. Martino University Hospital Medical School of Messina, 98125 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Koniari","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of South Manchester, NHS Foundation Trust, Manchester M23 9LT, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0384-2097","authenticated-orcid":false,"given":"Jawahar L.","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Arkansas for Medical Sciences and the Veterans Affairs Medical Center, Little Rock, AR 72205, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9751-6710","authenticated-orcid":false,"given":"Nicholas G.","family":"Kounis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Cardiology, University of Patras Medical School, 26221 Patras, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jamainternmed.2020.7986","article-title":"Antibodies, immunity, and COVID-19","volume":"81","author":"Spellberg","year":"2021","journal-title":"JAMA Int. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kounis, N.G., Koniari, I., de Gregorio, C., Velissaris, D., Petalas, K., Brinia, A., Assimakopoulos, S.F., Gogos, C., Kouni, S.N., and Kounis, G.N. (2021). Allergic reactions to current available COVID-19 vaccinations: Pathophysiology, causality, and therapeutic considerations. Vaccines, 9.","DOI":"10.3390\/vaccines9030221"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/10760296211021498","article-title":"An update on the Pathogenesis of COVID-19 and the reportedly rare thrombotic events following vaccination","volume":"27","author":"Kantarcioglu","year":"2021","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kounis, N.G., Koniari, I., de Gregorio, C., Assimakopoulos, S.F., Velissaris, D., Hung, M.Y., Mplani, V., Saba, L., Brinia, A., and Kouni, S.N. (2021). COVID-19 disease, women\u2019s predominant non-heparin vaccine-induced thrombotic thrombocytopenia and Kounis Syndrome: A passepartout cytokine storm interplay. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080959"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/a-1469-7481","article-title":"Diagnosis and management of vaccine-related thrombosis following astrazeneca COVID-19 vaccination: Guidance statement from the GTH","volume":"41","author":"Oldenburg","year":"2021","journal-title":"Hamostaseologie"},{"key":"ref_7","first-page":"173","article-title":"Heparin-induced thrombocytopenia","volume":"16","author":"Kelton","year":"1986","journal-title":"Haemostasis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0037-1615574","article-title":"Heparin-induced thrombocytopenia. Pathogenesis and treatment","volume":"82","author":"Greinacher","year":"1999","journal-title":"Thromb. Haemost."},{"key":"ref_9","first-page":"101061","article-title":"Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases","volume":"39","author":"Taquet","year":"2021","journal-title":"E Clin. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/STR.0b013e31820a8364","article-title":"Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Saposnik","year":"2011","journal-title":"Stroke"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"D\u2019Agostino, V., Caranci, F., Negro, A., Piscitelli, V., Tuccillo, B., Fasano, F., Sirabella, G., Marano, I., Granata, V., and Grassi, R. (2021). A Rare Case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration. J. Pers. Med., 11.","DOI":"10.3390\/jpm11040285"},{"key":"ref_12","unstructured":"(2021, March 31). European Medicines Agency: Signal Assessment Report on Embolic and Thrombotic Events (SMQ) with COVID-19 Vaccine (ChAdOx1-S\u2013COVID-19 Vaccine AstraZeneca (Other Viral Vaccines). Available online: https:\/\/www.ema.europa.eu\/en\/documents\/practical-recommendation."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bbi.2021.04.006","article-title":"Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination\u2014A report of two UK cases","volume":"95","author":"Mehta","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2021.7517","article-title":"US Case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021","volume":"325","author":"See","year":"2021","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/14760584.2021.1940145","article-title":"Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)","volume":"20","author":"Esba","year":"2021","journal-title":"Exp. Rev. Vaccines"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105938","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105938","article-title":"Vaccine-Induced Immune Thrombotic Thrombocytopenia with disseminated intravascular coagulation and death following the ChAdOx1 nCoV-19 Vaccine","volume":"30","author":"Aladdin","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S0140-6736(21)00872-2","article-title":"Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"397","author":"Bayas","year":"2021","journal-title":"Lancet"},{"key":"ref_18","unstructured":"Bj\u00f8rnstad-Tuveng, T.H., Rudjord, A., and Anker, P. (2021). Fatal cerebral haemorrhage after COVID-19 vaccine. Tidsskr. Den Nor. Legeforening, 141."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.3346\/jkms.2021.36.e223","article-title":"Intracerebral Hemorrhage due to thrombosis with thrombocytopenia syndrome after vaccination against COVID-19: The First fatal case in Korea","volume":"36","author":"Choi","year":"2021","journal-title":"J. Korean Med. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Crossette-Thambiah, C., Pericleous, C., Asmar, N., Bomsztyk, J., Ranger, A., Shlebak, A., Ramji, S., Banerjee, S., Laffan, M., and Arachchillage, D.J. (2021). Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination. J. Neurol. Neurosurg. Psychiatry.","DOI":"10.1136\/jnnp-2021-327340"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41467-021-25010-x","article-title":"Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: A catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia","volume":"12","author":"Iacobucci","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105906","article-title":"Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine","volume":"30","author":"Dias","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"102184","DOI":"10.1016\/j.dsx.2021.06.021","article-title":"Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation","volume":"15","author":"Dutta","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_24","first-page":"5063","article-title":"Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: A report of an autoptic case and review of the literature","volume":"25","author":"Fanni","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.thromres.2021.04.001","article-title":"Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination","volume":"202","author":"Franchini","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gattringer, T., Gressenberger, P., Gary, T., W\u00f6lfler, A., Kneihsl, M., and Raggam, R.B. (2021). Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination. Stroke Vasc. Neurol.","DOI":"10.1136\/svn-2021-001142"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100889","DOI":"10.1016\/j.accpm.2021.100889","article-title":"Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience","volume":"40","author":"Geeraerts","year":"2021","journal-title":"Anaesth. Crit. Care. Pain Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"E301","DOI":"10.1002\/ajh.26237","article-title":"Successful treatment of thrombotic thrombocytopenia with cerebral sinus venous thrombosis following Ad26.COV2.S vaccination","volume":"96","author":"George","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gessler, F., Schmitz, A.K., Dubinski, D., Bernstock, J.D., Lehmann, F., Won, S.Y., Wittstock, M., G\u00fcresir, E., Hadjiathanasiou, A., and Zimmermann, J. (2021). Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2 vaccination in vaccine induced thrombotic thrombocytopenia-VITT. J. Clin. Med., 10.","DOI":"10.3390\/jcm10132777"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1007\/s00415-021-10599-2","article-title":"Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in SARS-COVID-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis","volume":"268","author":"Graf","year":"2021","journal-title":"J. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ikenberg, B., Demleitner, A.F., Thiele, T., Wiestler, B., G\u00f6tze, K., M\u00f6\u00dfmer, G., and Lingoret, P. (2021). Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan. Stroke Vasc. Neurol.","DOI":"10.1136\/svn-2021-001095"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s00134-021-06425-y","article-title":"Fatal cerebral venous sinus thrombosis after COVID-19 vaccination","volume":"47","author":"Jamme","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.25259\/SNI_689_2021","article-title":"A rare case of vaccine-induced immune thrombosis and thrombocytopenia and approach to management","volume":"12","author":"Kotal","year":"2021","journal-title":"Surg. Neurol. Int."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1111\/ene.15029","article-title":"Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: An analysis of cases notified to the European Medicines Agency","volume":"28","author":"Krzywicka","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"738329","DOI":"10.3389\/fneur.2021.738329","article-title":"Cerebral venous sinus thrombosis, pulmonary embolism, and thrombocytopenia after COVID-19 vaccination in a Taiwanese Man: A case report and literature review","volume":"12","author":"Lin","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s44158-021-00020-9","article-title":"Cerebral venous sinus thrombosis (CVST) associated to SARS-CoV-2 vaccines: Clues for an immunopathogenesis common to CVST observed in COVID-19","volume":"1","author":"Mazzeo","year":"2021","journal-title":"Analg. Crit. Care"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(21)01608-1","article-title":"CVT After Immunisation Against COVID-19 (CAIAC) collaborators. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: A multicentre cohort study","volume":"398","author":"Perry","year":"2021","journal-title":"Lancet"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3324\/haematol.2021.279075","article-title":"Post-mortem findings in vaccine-induced thrombotic thombocytopenia","volume":"106","author":"Pomara","year":"2021","journal-title":"Haematologica"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.26172","article-title":"COVID-19 Vaccine-associated cerebral venous thrombosis in Germany","volume":"90","author":"Schulz","year":"2021","journal-title":"Ann. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2100956","DOI":"10.1183\/13993003.00956-2021","article-title":"Vaccination against COVID-19: Insight from arterial and venous thrombosis occurrence using data from VigiBase","volume":"58","author":"Smadja","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/bloodadvances.2021004904","article-title":"Case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2","volume":"5","author":"Rolland","year":"2021","journal-title":"Blood Adv."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e933397","DOI":"10.12659\/AJCR.933397","article-title":"Central venous sinus thrombosis with subarachnoid hemorrhage following an mRNA COVID-19 vaccination: Are these reports merely co-incidental?","volume":"22","author":"Syed","year":"2021","journal-title":"Am. J. Case Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e243931","DOI":"10.1136\/bcr-2021-243931","article-title":"ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST)","volume":"14","author":"Suresh","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-0040-1717078","article-title":"Characterization of new monoclonal PF4-specific antibodies as useful tools for studies on typical and autoimmune heparin-induced thrombocytopenia","volume":"121","author":"Vayne","year":"2021","journal-title":"Thromb. Haemost."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"721146","DOI":"10.3389\/fneur.2021.721146","article-title":"Vaccine induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high fatality rate: A case series","volume":"12","author":"Wiedmann","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wolf, M.E., Luz, B., Niehaus, L., Bhogal, P., B\u00e4zner, H., and Henkes, H. (2021). Thrombocytopenia and Intracranial venous sinus thrombosis after \u201cCOVID-19 vaccine AstraZeneca\u201d exposure. J. Clin. Med., 10.","DOI":"10.3390\/jcm10081599"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Yahyavi-Firouz-Abadi, N., and Naik, R.P. (Neuroradiol. J., 2021). Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia, Neuroradiol. J., in press.","DOI":"10.1177\/19714009211036687"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00701-021-04860-w","article-title":"Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine","volume":"163","author":"Zakaria","year":"2021","journal-title":"Acta Neurochir."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jamacardio.2021.3444","article-title":"Clinical Characteristics and pharmacological management of COVID-19 vaccine-induced immune thrombotic thrombocytopenia with cerebral venous sinus thrombosis: A review","volume":"6","author":"Rizk","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"117607","DOI":"10.1016\/j.jns.2021.117607","article-title":"Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review","volume":"428","author":"Bahmanyar","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(21)01788-8","article-title":"Cerebral venous sinus thrombosis after vaccination: The UK experience","volume":"398","author":"Lee","year":"2021","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejim.2021.05.026","article-title":"SARS-CoV-2 vaccine-induced cerebral venous thrombosis","volume":"89","author":"Ciccone","year":"2021","journal-title":"Eur. J. Intern. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e2200","DOI":"10.1212\/WNL.0000000000010598","article-title":"Trends in incidence and epidemiologic characteristics of cerebral venous thrombosis in the United States","volume":"95","author":"Otite","year":"2020","journal-title":"Neurology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ene.13381","article-title":"European stroke organization guideline for the diagnosis and treatment of cerebral venous thrombosis-endorsed by the European academy of neurology","volume":"24","author":"Ferro","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation","volume":"341","author":"Levi","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/0883073807307976","article-title":"Cerebral venous sinus thrombosis in children: A multicenter cohort from the United States","volume":"23","author":"Wasay","year":"2008","journal-title":"J. Child Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1056\/NEJMra2106545","article-title":"Cerebral venous thrombosis","volume":"385","author":"Ropper","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_61","unstructured":"European Medicines Agency (2021, June 08). AstraZeneca\u2019s COVID-19 Vaccine: EMA Finds Possible Link to Very Rare Cases of Unusual Blood Clots with Low Blood Platelets. EMA Website., Available online: https:\/\/www.ema.europa.eu\/en\/news\/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood."},{"key":"ref_62","first-page":"n1114","article-title":"Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: Population based cohort study","volume":"373","author":"Lund","year":"2021","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neurol.2020.04.014","article-title":"Acute meningoencephalitis in a patient with COVID-19","volume":"176","author":"Chaumont","year":"2020","journal-title":"Rev. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","article-title":"Registry of arterial and venous thromboembolic complications in patients with COVID-19","volume":"76","author":"Piazza","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"102804","DOI":"10.1016\/j.transci.2020.102804","article-title":"COVID-19, induced activation of hemostasis, and immune reactions: Can an auto-immune reaction contribute to the delayed severe complications observed in some patients?","volume":"59","author":"Amiral","year":"2020","journal-title":"Transfus. Apher. Sci."},{"key":"ref_66","first-page":"281","article-title":"Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): A position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET)","volume":"19","author":"Gresele","year":"2021","journal-title":"Blood Transfus."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Terpos, E., Politou, M., Ntanasis-Stathopoulos, I., Karalis, V., Merkouri, E., Fotiou, D., Gavriatopoulou, M., Malandrakis, P., Kastritis, E., and Trougakos, I.P. (2021). High prevalence of anti-PF4 antibodies following ChAdOx1 nCov-19 (AZD1222) vaccination even in the absence of thrombotic events. Vaccines, 9.","DOI":"10.3390\/vaccines9070712"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.STR.0000117571.76197.26","article-title":"Prognosis of cerebral vein and dural sinus thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT)","volume":"35","author":"Ferro","year":"2004","journal-title":"Stroke"},{"key":"ref_69","unstructured":"Virchow, R.L.K. (1856). Thrombose und Embolie. Gef\u00e4\u00dfentz\u00fcndung und Septische Infektion. Gesammelte Abhandlungen zur Wissenschaftlichen Medicin, Von Meidinger & Sohn."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1159\/000083845","article-title":"Virchow\u2019s triad revisited: Abnormal flow","volume":"33","author":"Lowe","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2459\/JCM.0000000000001232","article-title":"Concerning the unexpected prothrombotic state following some coronavirus disease 2019 vaccines","volume":"23","author":"Calcaterra","year":"2022","journal-title":"J. Cardiovasc. Med."},{"key":"ref_72","first-page":"277","article-title":"Varicose symptoms without varicose veins: The hypotonic phlebopathy, epidemiology and pathophysiology. The Acireale project","volume":"48","author":"Andreozzi","year":"2000","journal-title":"Minerva Cardioangiol."},{"key":"ref_73","first-page":"e213619","article-title":"Cerebral venous sinus thrombosis with thrombocytopenia syndrome study group. characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"78","author":"Poli","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"105678","DOI":"10.1016\/j.clineuro.2020.105678","article-title":"Probable risk factors of internal jugular vein stenosis in Chinese patients. A real-world cohort study","volume":"191","author":"Bai","year":"2020","journal-title":"Clin Neurol. Neurosurg."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Wang, L., Harrison, J., Dranow, E., Aliyev, N., and Khor, L. (Ann. Intern. Med., 2021). Accuracy of ultrasound jugular venous pressure height in predicting central venous congestion, Ann. Intern. Med., in press.","DOI":"10.7326\/L22-0118"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Tomar, B., Anders, H.J., Desai, J., and Mulay, S.R. (2020). Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19. Cells, 9.","DOI":"10.3390\/cells9061383"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jaci.2017.12.971","article-title":"Vaccine-associated hypersensitivity","volume":"141","author":"McNeil","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Tanno, L.K., Berard, F., Beaudoin, E., Didier, A., Demoly, P., and on behalf of the Montpellier WHO Collaborating Center (2021). SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center. Vaccines, 9.","DOI":"10.3390\/vaccines9060560"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1016\/j.jaip.2021.09.039","article-title":"Tolerability of polysorbate 80-containing COVID-19 vaccines in confirmed polyethylene glycol-allergic patients","volume":"9","author":"Ieven","year":"2021","journal-title":"J. All. Clin. Immunol. Pract."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Rhim, J.W., Kang, J.H., and Lee, K.Y. (Clin. Exp. Pediatr., 2022). Etiological and pathophysiological enigmas of severe coronavirus disease 2019, multisystem inflammatory syndrome in children, and Kawasaki disease, Clin. Exp. Pediatr., in press.","DOI":"10.3345\/cep.2021.01270"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Allegra, A., Di Gioacchino, M., Tonacci, A., Musolino, C., and Gangemi, S. (2020). Immunopathology of SARS-CoV-2 infection: Immune cells and mediators, prognostic factors, and immune-therapeutic implications. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134782"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-pathmechdis-012419-032847","article-title":"DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation","volume":"15","author":"Zindel","year":"2020","journal-title":"Annu. Rev. Pathol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/2\/232\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:13:35Z","timestamp":1760134415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/2\/232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":83,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["vaccines10020232"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10020232","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]}}}